Sound Wave Innovation sits in the small group of ultrasound neuromodulation companies applying non-invasive stimulation to neurodegenerative disease. Its positioning is differentiated by a Japan-led pivotal Alzheimer’s trial and a PMDA breakthrough designation, with commercialization tied to clinical readout and approval.